Irritable Bowel Syndrome With Constipation Clinical Trials

37 clinical trials for Irritable Bowel Syndrome With Constipation across international registries, including 4 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Study of Virtual Reality and Linaclotide for IBS-C — RECRUITING · NA
• Safety Study of Tenapanor for the Treatment of Pediatric Patients (6 to Less Than 18 Years Old) With IBS-C — RECRUITING · PHASE3
• Home Transcutaneous Electrical Acustimulation (TEA) — RECRUITING · PHASE2
• Effect of Consuming a Nutraceutical Composition on Signs and Symptoms in Adult Patients With Irritable Bowel Syndrome — RECRUITING · NA
• Effect of Tai Chi as Treatment for IBS-C — COMPLETED · NA
• Study to Assess Safety and Efficacy of Tenapanor for Treatment of IBS-C in Pediatric Patients 12 to Less Than 18 Years — ACTIVE_NOT_RECRUITING · PHASE3
• 4-Week, Multi-center Dose-Ranging Study for the IBS-C in Pts. 6 to <12 Yrs — ACTIVE_NOT_RECRUITING · PHASE2
• Electro-acupuncture for Irritable Bowel Syndrome With Constipation — COMPLETED · NA
• Long-term Safety of Linaclotide in Pediatric Participants With FC or IBS-C — COMPLETED · PHASE3
• Efficacy and Safety of Plecanatide in Children 6 to <18 Years With Irritable Bowel Syndrome With Constipation (IBS-C) — COMPLETED · PHASE2
• A Non-Interventional Pilot Study to Explore the Role of Gut Flora in IBS — WITHDRAWN
• Linaclotide Safety and Efficacy in Pediatric Participants, 6 to 17 Years of Age, With Irritable Bowel Syndrome With Constipation (IBS-C) or Functional Constipation (FC) — COMPLETED · PHASE3
• Post-marketing Surveillance of Linaclotide Tablet in Patients With Irritable Bowel Syndrome With Constipation or Chronic Constipation (Excluding Constipation Due to Organic Diseases) — COMPLETED
• Phase III Study to Evaluate the Efficacy and Safety of ASP0456 in Patients With Constipation Predominant Irritable Bowel Syndrome — COMPLETED · PHASE3
• IBS-C Questionnaire Study — COMPLETED
• A Multistrain Probiotic in Patients With Irritable Bowel Syndrome With Predominant Constipation — COMPLETED · NA
• Safety and Efficacy of Non-alcoholic Beverage Based on Kombucha in Patients With Constipations — COMPLETED · NA
• Personalized Dietary Intervention Based on Microbiome Analysis vs FODMAP Diet for Irritable Bowel Syndrome — OTHER · NA
• Efficacy and Safety of SYN-010 in IBS-C — TERMINATED · PHASE2
• Efficacy and Safety, Tolerability of GA-AT0119 in IBS-C — OTHER · NA
• A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation — TERMINATED · PHASE2
• An Evaluation of Cultured Milk Drink on Immune Status of Patients With Irritable Bowel Syndrome: Constipation Predominant — COMPLETED · NA
• Efficacy and Safety of a Food Supplement With Standardized Menthol, Limonene, and Gingerol Content in Patients With Irritable Bowel Syndrome — COMPLETED · NA
• Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C) — COMPLETED · PHASE2
• Efficacy and Safety of Lubiprostone in Patients With Irritable Bowel Syndrome With Constipation — COMPLETED · PHASE3
• An Open-Label, Long-term Study to Assess the Immunogenicity of LINZESS® (Linaclotide) Administered Orally to Adult Participants With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation — COMPLETED · PHASE4
• The Effect of CSP01 on Chronic Idiopathic Constipation and Irritable Bowel Syndrome With Constipation — COMPLETED · NA
• An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation — COMPLETED · PHASE3
• A Study of the Effect of SYN-010 on Subjects With IBS-C — COMPLETED · PHASE2
• A Single-Dose, Open-Label, Study to Evaluate the Sustainability of the Effects of SYN-010 in Patients With IBS-C — COMPLETED · PHASE2
• Investigation of Linaclotide's Effect on the Bi-directional Brain and Gut Axis in IBS-C Patients — COMPLETED · NA
• An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation — COMPLETED · PHASE3
• A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C) — COMPLETED · PHASE3
• Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C) — COMPLETED · PHASE3
• Randomized, Double-blind, Dose-range-finding, Phase 2 Study of Linaclotide Administered to Patients With Irritable Bowel Syndrome With Constipation (IBS-C) — COMPLETED · PHASE2
• A Treatment Investigational New Drug (tIND) Program of Tegaserod in Women With Irritable Bowel Syndrome With Constipation or With Chronic Idiopathic Constipation — TERMINATED
• A Study to Evaluate the Safety, Tolerability and Pharmacodynamics of DDP733 for IBS-c — COMPLETED · PHASE2

Refine this search